Takimoto Y, Imanaka F, Kouzai K, Okuhara T
Dept. of Internal Medicine, Hiroshima City Asa Hospital, Japan.
Gan To Kagaku Ryoho. 1996 Mar;23(4):495-8.
A 50-year-old male with acute myelocytic leukemia (AML) achieved complete remission after combination chemotherapy. However, the AML recurred after six months. He did not respond to various treatments and his condition deteriorated after chemotherapy. After we attempted continuous administration of cytosine arabinoside (Ara-C), the number of leukemic cells was controlled for nine months. During this period, he could stay and receive treatment with Ara-C at home. In this case, the continuous administration of Ara-C at home was truly effective not only to control the number of leukemic cells but also to improve the quality of life.
一名50岁的急性髓细胞白血病(AML)男性患者在联合化疗后实现了完全缓解。然而,6个月后AML复发。他对各种治疗均无反应,化疗后病情恶化。在我们尝试持续给予阿糖胞苷(Ara-C)后,白血病细胞数量得到控制达9个月。在此期间,他能够在家中接受Ara-C治疗。在这种情况下,在家中持续给予Ara-C不仅对控制白血病细胞数量有效,而且对改善生活质量也确实有效。